Differential activity of topotecan, irinotecan and SN-38 in fresh human tumour cells but not in cell lines

This publication has 18 references indexed in Scilit:

• Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
  The Lancet, 1998
• Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241)
  Investigational New Drugs, 1997
• Topoisomerase I inhibitors: Review and update
  Annals of Oncology, 1997
• CPT-11 in human colon-cancer cell lines and xenografts: Characterization of cellular sensitivity determinants
  International Journal of Cancer, 1997
• Future Directions for Clinical Research With CPT-11 (Irinotecan)
  European Journal Of Cancer, 1996
• Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance
  British Journal of Cancer, 1996
• Current perspectives on camptothecins in cancer treatment
  British Journal of Cancer, 1996
• Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice
  Anti-Cancer Drugs, 1996
• Topotecan in colorectal cancer: A phase II study of the EORTC early clinical trials group
  Annals of Oncology, 1995
• Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26
  Biochemistry, 1988